X

Trial Profile

A 24-month Randomised Parallel Group Single-blinded Multi-centre Phase 1 Pilot Study of AADvac1 in Patients With Non Fluent Primary Progressive Aphasia

Status: Active, no longer recruiting

Phase of Trial: Phase I

Latest Information Update: 02 Nov 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs AADvac 1 (Primary) ; Aluminium hydroxide
Indications Primary progressive aphasia
Focus Adverse reactions; Pharmacodynamics
Acronyms AIDA
Sponsors Axon Neuroscience

Most Recent Events

13 Nov 2019 Planned End Date changed from 1 Jul 2020 to 1 Nov 2020.
13 Nov 2019 Planned primary completion date changed from 1 Jul 2020 to 1 Nov 2020.
13 Nov 2019 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com